Adaptive Biotechnologies Corp Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Adaptive Biotechnologies Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
  • Adaptive Biotechnologies Corp Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $13.5M, a 11.8% decline year-over-year.
  • Adaptive Biotechnologies Corp Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $56.3M, a 8.62% decline year-over-year.
  • Adaptive Biotechnologies Corp annual Share-based Payment Arrangement, Expense for 2023 was $62.9M, a 13.4% increase from 2022.
  • Adaptive Biotechnologies Corp annual Share-based Payment Arrangement, Expense for 2022 was $55.5M, a 28.3% increase from 2021.
  • Adaptive Biotechnologies Corp annual Share-based Payment Arrangement, Expense for 2021 was $43.3M, a 74.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $62.9M +$7.43M +13.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $55.5M +$12.2M +28.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $43.3M +$18.5M +74.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $24.8M +$11.6M +88.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-14
2019 $13.1M +$1.98M +17.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 $11.1M +$4.14M +59.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $7.01M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.